News
-
-
-
PRESS RELEASE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE. TVM Capital Life Science announces a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology -
PRESS RELEASE
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 janvier 2024
EUROPLASMA déclare le nombre total de droits de vote et d'actions au 31 janvier 2024 conformément aux réglementations en vigueur. L'entreprise propose des solutions innovantes pour le traitement et la valorisation des déchets dangereux -
-
PRESS RELEASE
SOWITEC and Cubico Sustainable Investments sign contract for the development of renewable energy projects in Mexico with a capacity of 800 MW
SOWITEC and Cubico Sustainable Investments sign contract for 800 MW renewable energy projects in Mexico, including wind and solar projects, with secured land and permits. The agreement reflects SOWITEC's long-term market potential in the region and Cubico's commitment to reducing greenhouse gas emissions and driving economic growth in Mexico -
-
PRESS RELEASE
Original-Research: Rubean AG (von NuWays AG): BUY
Rubean AG has reported a record-breaking monthly turnover in January 2024, driven by a significant increase in user numbers and contract work. This performance is expected to lead to strong sales growth and potential positive newsflow from new partnerships in the coming months -
-
PRESS RELEASE
Original-Research: Cantourage Group SE (von NuWays AG): BUY
Cantourage Group SE receives a buy rating with a target price of €11, following the approval of the 'Cannabis Act' in Germany, expected to take effect on April 1st. The act will allow adults to possess cannabis and establish non-profit cannabis clubs, benefiting established players like Cantourage
